Metagenics, Inc. (Aliso Viejo, CA) has announced that Sara Gottfried, MD has been named its new chief medical officer (CMO) and president of Metagenics Institute, the company’s educational arm. A systems-based hormone expert, Dr. Gottfried is a Harvard-educated physician-scientist and a MIT-trained bioengineer as well as board certified in Obstetrics and Gynecology.
In her new role at Metagenics, Dr. Gottfried will drive overall education and practitioner outreach strategy and provide insights on emerging areas of clinical interest. She will be a part of the company’s global leadership team, supporting further international expansion, and engage and drive support with industry key opinion leaders around the world.
Dr. Gottfried is a New York Times best-selling author of three books: The Hormone Cure, The Hormone Reset Diet and Younger. She is also the founder and CMO of the Gottfried Institute, where she has taught health care professionals—including medical, naturopathic, osteopathic and chiropractic physicians, as well as acupuncturists, nutritionists and health coaches—methods focused on rebalancing hormones and advancing health span of their clients using her proprietary and evidence-based 3-Step Gottfried Protocol. Previously, Dr. Gottfried has taught on the adjunct faculty at the University of California at San Francisco and Touro University College of Osteopathic Medicine and performed clinical research at the Brigham and Women’s Hospital and Kaiser Permanente Division of Research in bioinformatics and breast cancer risk reduction.
“We are fortunate to have a chief medical officer of Dr. Gottfried’s caliber and experience step in to lead our education,” said Brent Eck, Metagenics CEO. “Dr. Gottfried shares our vision of helping practitioners along their lifestyle medicine journey as well as making personalized nutritional intervention the standard of care in the promotion of optimal health. As a functional medicine practitioner, she has firsthand experience in how making lifestyle changes can help patients reclaim their lives. We’re excited for her to bring her knowledge and experience to Metagenics as we enter our next chapter of lifestyle education.”
“The opportunity to help Metagenics in its mission to drive a fundamental shift in healthcare, here in the United States and around the world, captured my attention in a profound way,” remarked Dr. Gottfried. “Metagenics has created a uniquely collaborative ecosystem dedicated to robust science, research, quality and support of clinicians. As a strong advocate for patients’ and clinicians’ wellbeing, these values are essential to me. I look forward to developing a comprehensive, leading-edge educational strategy that better serves existing clinicians and enables more practitioners to make the transition to personalized lifestyle medicine.”
For more information, visit www.metagenics.com.